- GL-Co-Management of Glaucoma Laser and MIGS Procedures
- GL-First Line Glaucoma Treatment...What is It
- GL-Glaucoma Masqueraders
- GL-Maximizing OCT Interpretation in Glaucoma
- GL-Ocular Surface Preservation for the Glaucoma Patient. Prevent Defense is the Best Offense.
- GL-Problem Solving in Glaucoma Management
- GL-Referral Center Rounds: Mysterious Reasons of Elevated IOP
- GL-The Laser and Surgical Management of Glaucoma
- GL-The OD's Role in the Management of MIGS in 2022
- GL-The Secondary Glaucomas: From the OD and MD Perspective
- GL-Utilizing OCT Technology to Differentiate Glaucoma Suspects from Early Manifest Disease
GL-Now What?...My Patient is Progressing!
Description:
What are the next steps when a patient with glaucoma is not stable after treatment has been initiated? This course will review a variety of different scenarios and treatment options to address the common problem that many optometrists encounter. What do I do next? Diagnosing glaucoma can be challenging, but as challenging is knowing what to do next when the patient continues to progress.
Course Code:
AOA291-GL
Speaker(s):
Justin Schweitzer, O.D.
justin.schweitzer@vancethompsonvision.com
Walter Whitley, O.D.
wowhitley@gmail.com
Nathan Lighthizer, O.D.
lighthiz@nsuok.edu
Credits:
1
AOA Expiration Date:
3/3/2025
Constant presence: Alliance builds reputation for patient safety advocacy
Founded five years ago, the Health Care Alliance for Patient Safety (HCAPS) is making good on its mission to advocate for patient safety and protect the fundamental doctor-patient relationship. The alliance’s advocacy will be recognized with the AOA’s Apollo Award during a ceremony at the 2023 Optometry’s Meeting® June 21-24.
What defines the value of care we provide?
Health and vision plans have not adapted and grown with the care we deliver but hold back optometry’s momentum.
How to speak the universal language of care
How to create a bilingual and culturally sensitive practice, why it matters to patients and how it can set you apart from the competition.